Bifunctional Chimera That Coordinately Targets Human Immunodeficiency Virus 1 Envelope gp120 and the Host-Cell CCR5 Coreceptor at the Virus-Cell Interface

Journal of Medicinal Chemistry
Adel A RashadIrwin Chaiken

Abstract

To address the urgent need for new agents to reduce the global occurrence and spread of AIDS, we investigated the underlying hypothesis that antagonists of the HIV-1 envelope (Env) gp120 protein and the host-cell coreceptor (CoR) protein can be covalently joined into bifunctional synergistic combinations with improved antiviral capabilities. A synthetic protocol was established to covalently combine a CCR5 small-molecule antagonist and a gp120 peptide triazole antagonist to form the bifunctional chimera. Importantly, the chimeric inhibitor preserved the specific targeting properties of the two separate chimera components and, at the same time, exhibited low to subnanomolar potencies in inhibiting cell infection by different pseudoviruses, which were substantially greater than those of a noncovalent mixture of the individual components. The results demonstrate that targeting the virus-cell interface with a single molecule can result in improved potencies and also the introduction of new phenotypes to the chimeric inhibitor, such as the irreversible inactivation of HIV-1.

References

Jun 20, 2003·Nature Reviews. Drug Discovery·Erik De Clercq
Jul 3, 2004·The Journal of Antimicrobial Chemotherapy·Michael L Greenberg, Nick Cammack
May 4, 2006·The Journal of Pharmacology and Experimental Therapeutics·Ronald J Tallarida
Jul 10, 2007·Lancet·José A Esté, Amalio Telenti
Aug 12, 2008·Clinical Therapeutics·Sharon S Lieberman-BlumJuan C Bandres
Dec 23, 2008·The Journal of Biological Chemistry·Changhua JiSurya Sankuratri
Apr 2, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Raymond YostEric G Sahloff
Apr 27, 2010·Journal of Medicinal Chemistry·Valentina BorsiNiko Sarti
Aug 3, 2010·ChemMedChem·Muddegowda UmashankaraIrwin Chaiken
Oct 20, 2010·Antimicrobial Agents and Chemotherapy·Ioannis KagiampakisPatricia J LiWang
Jun 11, 2011·The Journal of Biological Chemistry·Bo ZhaoPatricia J Liwang
Jun 30, 2011·ChemMedChem·Arangassery R BastianIrwin Chaiken
Nov 16, 2011·Antimicrobial Agents and Chemotherapy·Karyn McFaddenIrwin Chaiken
Aug 22, 2012·Cold Spring Harbor Perspectives in Medicine·Craig B WilenRobert W Doms
Dec 15, 2012·ChemMedChem·Kantharaju KamannaIrwin M Chaiken
Apr 13, 2013·Journal of Computer-aided Molecular Design·G Madhavi SastryWoody Sherman
Nov 2, 2013·Science·Jean-Philippe JulienIan A Wilson
Feb 25, 2014·ACS Medicinal Chemistry Letters·Shigehiro AsanoCarlos F Barbas
Apr 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Laura Martínez-MuñozMario Mellado
Oct 9, 2014·Nature·Marie PanceraPeter D Kwong

❮ Previous
Next ❯

Citations

Apr 20, 2019·Medicinal Research Reviews·Xiangyi JiangPeng Zhan
Sep 23, 2020·Archiv der Pharmazie·Lian-Shun FengDuan Liu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.